[1] 陈清艳,王秋实. 新生儿溶血病发病机制及产前诊断研究进展[J]. 临床输血与检验,2021,23(5):578-584. [2] 卢亚敏,邢晨皓,陈芳,等. VCAM-1、MCP-1、IL-17、IL-6在桥本甲状腺炎患者不同甲状腺抗体水平下的作用[J]. 暨南大学学报(自然科学与医学版),2023,44(5):521-527. [3] 庄园,杜璐雁,单海霞,等. 血清CKMB、ALP及AST的表达水平及对高胆红素血症新生儿的临床意义[J]. 分子诊断与治疗杂志,2024,16(4):717-720. [4] 李翠莹,李小薇. 胎儿新生儿溶血病实验室检测专家共识[J]. 临床输血与检验,2021,23(1):20-23. [5] NOSAKA M,ISHIDA Y,TANAKA A,et al.Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites[J]. J Histochem Cytochem,2008,56(3):223-231. [6] 杨旭,杨讯,许词,等. 内皮微颗粒对新生儿ABO溶血病预后价值的研究[J]. 实验与检验医学,2021,39(2):305-308. [7] 鲁广建,王侠,张晨光,等. CD144+内皮微粒标志物与母婴血型不合新生儿溶血病患儿血管内皮损伤及功能障碍的相关性研究[J]. 中国妇幼保健,2015,30(16):2528-2531. [8] 刘鹏,丁建娥,姜丹丹,等. 血管内皮钙黏蛋白与ABO新生儿溶血病患儿血管内皮损伤的相关性研究[J]. 临床输血与检验,2022,24(1):80-83. [9] 丁建娥,姜丹丹,丁金钰,等. 孕晚期血管内皮损伤标志物对ABO型胎儿新生儿溶血病的产前诊断预测意义[J]. 当代医学,2022,28(21):17-20. [10] PICKETT J R,WU Y A,ZACCHI L F,et al.Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis:drug discovery and development of vascular cell adhesion molecule-1-directed novel therapeutics[J]. Cardiovasc Res,2023,119(13):2278-2293. [11] TRONCOSO M F,ORTIZ-QUINTERO J,GARRIDO-MORENO V,et al.VCAM-1 as a predictor biomarker in cardiovascular disease[J]. Biochim Biophys Acta Mol Basis Dis,2021,1867(9):166170. [12] TRONCOSO M F,DÍAZ-VESGA M C,SANHUEZA-OLIVARES F,et al. Targeting VCAM-1:a therapeutic opportunity for vascular damage[J]. Expert Opin Ther Targets,2023,27(3):207-223. [13] 张晨光,吴子钊,王亚荣,等. ABO新生儿溶血病与O型孕妇血清中IgG及其亚类含量的相关分析[J]. 中国输血杂志,2007,20(1):15-17. [14] 任晓坤,史天威,余红星. 新生儿ABO溶血病相关母亲因素分析[J]. 中国优生与遗传杂志,2011,19(11):87-88. [15] AWAD H A E,TANTAWY A A G,EL-FARRASH R A,et al. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility[J]. Blood Transfus,2014,12(2):250-259. [16] AGRE P,CARTRON J P.Molecular biology of the Rh antigens[J]. Blood,1991,78(3):551-563. |